Gecacitinib + ZG005 + BEVACIZUMAB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Gecacitinib + ZG005 + BEVACIZUMAB
Treatment and conditionWhere it standsTrials
Gecacitinib + ZG005 + BEVACIZUMAB for uterine cervical neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1